StockData
Pliant Therapeutics, Inc. logo

Pliant Therapeutics, Inc. (PLRX) income statement

PLRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 3/30
$0.60−0.02 (-4.02%)

Close on Nov 20, 2026Market cap $36.85MP/E –Yield 0.00%

See a number that looks wrong?